CAS No: 50906-53-1

50907-10-3 Cyclopropanecarboxylic acid, 2,2-dimethyl-3-(2-methyl-1-propenyl)-,(2,6-dichlorophenyl)methyl ester

62268-94-4 1H-Isoindol-1-one,3-[bromo(4-nitrophenyl)methylene]-2,3-dihydro-2-(phenylmethyl)-

6226-89-7 1,3,6-Naphthalenetrisulfonic acid,7-hydroxy-8-[[4-(phenylazo)phenyl]azo]-, trisodium salt

50906-57-5 3β-[(4-O-β-D-Glucopyranosyl-6-deoxy-α-L-mannopyranosyl)oxy]-16β-hydroxy-5β-card-20(22)-enolide

62269-12-9 Butanamide, 2-[(2-hydroxyphenyl)hydrazono]-3-oxo-N-phenyl-, (Z)-

509076-56-6 Methanesulfonamide,N-[3-(3,5-dichlorophenoxy)-4-pyridinyl]-1,1,1-trifluoro-

509073-87-4 Pyridine, 2-(1-naphthalenyloxy)-

62269-15-2 Butanamide, N-(4-methoxyphenyl)-3-oxo-2-(phenylhydrazono)-, (Z)-

509078-50-6 4H-Furo[3,2-c][1]benzopyran-4-one,2-ethoxy-2,3-dihydro-3-(4-hydroxy-2-oxo-2H-1-benzopyran-3-yl)-

62269-09-4 Butanamide, 2-[(2-methoxyphenyl)hydrazono]-3-oxo-N-phenyl-, (Z)-

62269-06-1 Butanamide, 2-[(2-chlorophenyl)hydrazono]-3-oxo-N-phenyl-, (Z)-

62268-77-3 1H-Isoindol-1-one,2,3-dihydro-2-(2-methylphenyl)-3-[(4-nitrophenyl)methylene]-

509077-98-9 catumaxomab

50906-64-4 (13α,14β,17S,20ξ)-5α-Lanosta-8,24-diene-3,22-dione

5090-67-5 (3aS,6aβ,9bβ)-3a,4,5,6,6a,7,8,9,9a,9b-Decahydro-8β,9β-dihydroxy-6α,9aα-dimethyl-3-methyleneazuleno[4,5-b]furan-2(3H)-one

50906-83-7 Cathafoline

50906-95-1 3,6-anhydro-2,4,5-trideoxy-3,5,6-trimethyl-L-arabino-heptaric acid

62268-79-5 1H-Isoindol-1-one,2,3-dihydro-2-(4-methylphenyl)-3-[(4-nitrophenyl)methylene]-

62269-20-9 3-Penten-2-one, 3-methyl-4-[(trimethylsilyl)oxy]-, (Z)-

62269-01-6 Butanamide, 2-[(4-nitrophenyl)hydrazono]-3-oxo-N-phenyl-, (Z)-